Successful treatment of tardive lingual dystonia with botulinum toxin: Case report and review of the literature

2008 ◽  
Vol 32 (5) ◽  
pp. 1167-1171 ◽  
Author(s):  
Johannes M.H. Hennings ◽  
Eike Krause ◽  
Kai Bötzel ◽  
Thomas C. Wetter
2008 ◽  
Vol 69 (2) ◽  
pp. 117-120 ◽  
Author(s):  
Wei-Chieh Chang ◽  
Hsi-Kai Tsou ◽  
Ting-Hsien Kao ◽  
Meng-Yin Yang ◽  
Chiung-Chyi Shen

2011 ◽  
Vol 37 (12) ◽  
pp. 1798-1805 ◽  
Author(s):  
Jeffrey M. Melancon ◽  
Wynnis L. Tom ◽  
Robert A. Lee ◽  
Michelle Jackson ◽  
Shang I. Brian Jiang

2017 ◽  
Vol 4 (2) ◽  
Author(s):  
Samantha E. Jacobs ◽  
Deborah Saez-Lacy ◽  
Walter Wynkoop ◽  
Thomas J. Walsh

Abstract Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked improvement and minimal adverse effects. We further review the literature on antifungal management of ABPA.


Sign in / Sign up

Export Citation Format

Share Document